SCHEMBL4045000

SCHEMBL4045000

COc1ccc2c(c1)NC(c1ccc(Cl)cc1)(C(C(=O)NC1CCCC1)C1CCCCC1)N2

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.48
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
TSHR P16473 2/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
AVPR1A P37288 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
EPHX2 P34913 2/20 0.39
EPHX1 P07099 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
YAP1 P46937 1/20 0.39
TEAD4 Q15561 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038480 1.00 NR1H4 (0.48) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4037444 1.00 NR1H4 (0.48) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4042532 0.91 NPC1 (0.42) MEN1KMT2ATSHRNPC1RAB9A
SCHEMBL4039833 0.91 NPC1 (0.42) MEN1KMT2ATSHRNPC1RAB9A
SCHEMBL4035053 0.91 LMNA (0.44) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4038748 0.91 LMNA (0.44) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4041511 0.91 LMNA (0.44) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4044495 0.90 GRM5 (0.43) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4039126 0.90 GRM5 (0.43) NR1H4MEN1KMT2ATSHRNPC1
SCHEMBL4036196 0.90 GRM5 (0.43) NR1H4MEN1KMT2ATSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed